Update On FDA Advisory Committee Meeting On Liraglutide For The Treatment Of Type 2 Diabetes (Medical News Today)
Novo Nordisk announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has finalised its discussions of questions related to liraglutide, a once-daily human GLP-1 analogue. The Advisory Committee voted on questions related to the risk profile of liraglutide.

FDA Approves 40-Minute Bird Flu Test (Medical News Today)
The US Food and Drug Administration (FDA) announced on Tuesday this week that it had cleared for marketing a new, faster test for detecting bird flu (influenza type A/H5N1) in humans that only takes 40 minutes to identify a marker protein that confirms the presence of the virus subtype from a swab.

FDA Approves Label Change For Non-Invasive Fibroid Treatment (Medical News Today)
InSightec Ltd. announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate(R) 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.